Ozempic (semaglutide) prior authorization denied appeal

GLP-1 for type 2 diabetes

To appeal a denied prior authorization for Ozempic (semaglutide), file a written appeal within 180 days. The appeal must cite the insurer's clinical policy, include a letter of medical necessity from the prescriber, and document each criterion the policy requires. The most common winning evidence is documented prior therapy history and a specialist letter.

Typical PA criteria

  • Type 2 diabetes diagnosis (ICD-10 E11.x)
  • A1C above plan threshold (commonly 7.0)
  • Trial of metformin

Why your PA was denied

  • Off-label use for weight loss
  • Step therapy with metformin not documented
  • Missing A1C results
  • Quantity limit exceeded

Evidence that overturns the denial

  • ICD-10 E11.x in chart
  • Recent A1C result
  • Metformin trial history with dose and duration
  • Letter of medical necessity citing SUSTAIN trial data

Denials for off-label weight-loss use rarely overturn. For diabetes use, ensure the diagnosis code is on every claim.

Draft a Ozempic (semaglutide) appeal letter

Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.

Draft my appeal letter

FAQ

Why was my Ozempic (semaglutide) prior authorization denied?+

The most common reasons are: Off-label use for weight loss; Step therapy with metformin not documented; Missing A1C results. Your denial letter names the specific criteria you did not meet.

How do I appeal a Ozempic (semaglutide) denial?+

File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.

What evidence overturns a Ozempic (semaglutide) denial?+

ICD-10 E11.x in chart; Recent A1C result; Metformin trial history with dose and duration.

What if the plan excludes Ozempic (semaglutide) entirely?+

Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.

Other drugs

Not legal or medical advice. This page is a self-help resource. You make your own decisions. Strip personal identifiers (name, date of birth, address, member ID) from any document before uploading or sharing. The information here summarizes commonly-published payer policies and federal rules; confirm against your specific plan document and the current denial letter before acting.